Explore the words cloud of the MIRCAB project. It provides you a very rough idea of what is the project "MIRCAB" about.
The following table provides information about the project.
|Coordinator Country||Belgium [BE]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2015-01-01 to 2015-06-30|
Take a look of project's partnership.
Multiplicom will draft a business plan that is composed of the following parts: (i) selection of miRNAs for which there is substantial scientific evidence that such may be important for the diagnosis, treatment and/or prognosis of triple-negative breast cancer (“TNBC”) patients; (ii) perform a thorough analysis of the intellectual property on the selected miRNAs; (iii) start in-licensing negotiations with licensors regarding relevant intellectual property (iv) select a suitable quantitative multiplex miRNA analysis; (v) plan a European-wide, multi-center, clinical validation of the selected miRNAs using the selected multiplex quantification method (“Validation Study”); and (vi) perform a marketing study regarding the use of miRNA diagnosis/prognosis in TNBC patients; (vii) develop a competitive strategy
For part (i) Multiplicom has the support of top-notch clinical scientists (“KOLs”) in the field of miRNA in TNBC. Multiplicom will rely on its internal expertise, and expertise of its consultants to perform (ii) to (vi). This is supported by its track record of developing and commercializing novel highly multiplexed diagnostics (ISO 13485 & CE/IVD).
The global 170,000 cases of TNBC (new cases in 2012) constitute the target patient population to be monitored by the validated multiplex miRNA test kit (“Kit”) such that they can be offered the best treatment of what is a multi-billion Euro pharmaceutical opportunity. From presently available data Multiplicom estimates the annual peak sales of the Kit in excess of €5M, with a gross margin of >80%, allowing further expansion of the company including new hires in all departments.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIRCAB" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MIRCAB" are provided by the European Opendata Portal: CORDIS opendata.
Palliative care in Parkinson’s diseaseRead More
Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary networkRead More
Integrating and decentralising diabetes and hypertension services in AfricaRead More